Background and Purpose-Polyamines are mainly restricted to the intracellular space. During focal cerebral ischemia, polyamines are released from the intracellular compartment. Experimental studies have implicated a marked elevation in brain tissue and blood. The aim of our study was to investigate whether the elevation of polyamines in the blood of patients with focal cerebral ischemia correlates with the clinical outcome and the infarct volume. Methods-Polyamines were measured in 16 patients with focal cerebral ischemia and in 8 healthy control subjects. Blood samples for polyamine measurement were taken at admission and at fixed time points for the next 28 days. Polyamines were analyzed in red blood cells by a high-pressure liquid chromatography system. Clinical findings were recorded with the NIH Stroke Scale score. Volume of infarction was analyzed from cranial CT at admission and on days 4 to 6 after ischemia. Results-A significant increase of the spermidine level in the peripheral blood could be observed in all patients with focal cerebral ischemia as compared with control subjects ( 
T he endogenous polyamines putrescine, spermidine, and spermine are low-molecular-weight aliphatic amines that are found in high concentrations in the brain. 1 Polyamine metabolism is regulated by the activity of the first key enzyme ornithine decarboxylase (ODC). 2 Polyamines are predominantly found intracellularly, whereas only smaller amounts could be observed in the extracellular space or in the peripheral blood. 3 Animal studies have shown that polyamines play an important role in the ischemic cascade. 4, 5 Polyamines activate N-methyl-D-aspartate (NMDA) receptors, 6 -9 followed by a calcium influx. Other possible mechanisms are calcium-related events at the cell membrane 10, 11 and release of neurotransmitters from nerve endings. 11 However, polyamines have not been determined in clinical studies of cerebral ischemia, and their clinical significance is thus unknown.
Because polyamines are released from the intracellular compartment during focal cerebral ischemia, the aim of our study was to analyze their value as a marker of neuronal tissue destruction in the peripheral blood and a potential predictor for clinical outcome in the acute stage of stroke.
Subjects and Methods

Patients
The polyamine level was determined in 16 patients (6 women and 10 men; mean ageϮSD, 70.4Ϯ8.3 years) with a first-ever acute focal cerebral ischemia (Ͻ6 hours) of the middle cerebral artery (MCA) as determined by clinical signs and cranial CT. Adults of any age were included, and informed consent was obtained according to the Helsinki Declaration of Ethical Requirements. CT as well as blood samples were part of the routine workup.
Exclusion criteria were (1) brain stem or lacunar stroke, (2) a transient neurological deficit with rapid recovery during workup, (3) a previous ischemia in the same territory, and (4) primary or secondary cerebral hemorrhage with preexisting disability.
All patients underwent a complete cerebrovascular workup, including extracranial and transcranial Doppler ultrasound, electrocardiography, echocardiography, and serum investigations for exclusion of coagulation disorders.
An age-matched healthy group (68.8Ϯ15.3, nϭ8) with no previous neurological disorder or severe general disease served as control subjects. The level of polyamines was determined at the same time points as in the patient group.
Neuroimaging
All patients were scanned by cranial CT (GE ProSpeed SX Power, GE Medical Systems) at admission and on days 4 to 6 after ischemia. A set of 5-mm-thick, contiguous, axial CT images was obtained. The infarction volume was computed from the data set by the semiautomated infarct segmentation method. 12 The volume of infarction was measured within each slice and calculated to give a total volume. The obtained volume was correlated to the entire MCA territory according to anatomic guidelines 13 and defined as small infarctions (less than one third of the MCA territory), moderate infarctions (one third to two thirds of the MCA territory), and large infarctions (more than two thirds of the MCA territory).
Polyamine Analysis
Venous blood samples were collected without compression from all subjects at admission (within 6 hours after onset of symptoms), in the first 2 days every 6 hours, and on days 3, 5, 7, 14, and 28 after the onset of neurological symptoms. One patient died after 7 days and was excluded from further statistical analysis.
Cooled heparinized blood samples were immediately sedimented by centrifugation (5000 rpm, 2 minutes); plasma and leukocytes were carefully discarded. Erythrocytes were washed 3 times with isotone NaCl, hemolyzed with distilled water, and extracted with HClO 4 . The extract was neutralized with KOH and frozen at Ϫ40°C.
The neutralized extracts were derivatized with o-phthalaldehyde, and polyamines were separated by means of a reversed-phase HPLC column (Partisil 10 ODS 3, CS-Chromatographie Service) and quantified by fluorescence detection. 14 
Statistical Analysis
For the follow-up of the spermidine level, an unpaired Wilcoxon test with a Holm correction was used. For further evaluation, a multiple linear regression model was used. Statistical significance was set at PϽ0.01. Data are given as meanϮSD.
Results
Clinical Aspects
In 6 patients, a cardioembolic source of stroke was likely because of atrial fibrillation, mitral valve operation with stop of anticoagulation therapy, mitral valve insufficiency, and global heart insufficiency. Three patients showed paradox embolism caused by a patent foramen ovale with a right-toleft shunt. The other patients had obstructions of the internal carotid artery; in 2 patients, the underlying cause of ischemia remained undetermined.
Clinical Characteristics
Risk factors were determined for smoking, alcohol, hypercholesterolemia, diabetes, hypertension, heart insufficiency, and coagulation disorders. No correlation was found between the polyamine level and either of these risk factors.
NIH Stroke Score
The mean of the NIH Stroke Score at admission was 14.4Ϯ5.6 (range, 6 to 23; median, 14.0). Three patients had a severe stroke (NIH score Ն22), 10 had a moderate stroke (NIH score 10 to 22), and 3 had a mild stroke (NIH score Ͻ10).
Infarct Volume
All patients showed embolic infarction on the follow-up CT scan on day 4 after ischemia. The mean infarct volume was 95.1Ϯ98.2 mm 3 . In 2 patients, no early signs of stroke could be detected in the initial CT scan. In the control CT on day 4, all patients revealed an ischemic area with small infarcts in 7 patients, moderate infarctions in 5 patients, and large infarctions in 4 patients.
Spermidine Level in Red Blood Cells
In the control group, mean blood level for spermidine was 5.9Ϯ1.7 nmol/mL erythrocytes (range, 2.3 to 10.7 nmol/mL erythrocytes). There were no significant alterations in the spermidine level throughout the entire observation period (Figure 1 ). The polyamines spermine and putrescine were not detectable in each blood sample taken but showed a similar tendency as the spermidine values (data not shown). During the entire observation period, the spermidine level was higher than the level in the control group, with a marked increase at day 14 followed by a drop on day 28 (Figure 1) .
During the observation period, the spermidine level showed a nonsignificant generalized increase compared with control subjects (Figure 1) . A significant elevation of spermidine level in red blood cells compared with control values after focal cerebral ischemia could be seen at admission (PϽ0.0027), further at 6 hours after ischemia (PϽ0.0085), and on days 7 and 14 (PϽ0.0004, PϽ0.0005, respectively), followed by a marked drop on day 28 ( Figure 1 ).
Correlation of Spermidine Level With Clinical Outcome and Infarct Volume
For the determination of polyamines as a prognostic predictor, the spermidine levels were correlated with the clinical outcome (NIH Stroke Score on day 28) as well as with the infarct volume. At admission, there already was a significant correlation between the spermidine level and the NIH Stroke Score at day 28 (rϭ0.90; PϽ0.01) as well as with the infarct volume (rϭ0.91; PϽ0.01). Furthermore, there was a significant statistical correlation between several spermidine levels within the first 48 hours and clinical outcome (Figure 2) . No significant correlation was achieved between the final NIH score and the spermidine level at 18 hours and days 7 to 14, respectively.
Discussion
Several markers of neuronal tissue destruction such as neuron-specific enolase, lactate, myelinbasic proteins, proteolipid protein, and S-100 protein have been investigated to provide quantitative information about the extension of infarction to have early information for clinical prognosis. [15] [16] [17] [18] Most of these investigations were done in the cerebrospinal fluid by a lumbar puncture, which, however, does not represent a routine investigation in stroke patients. Therefore, markers detectable in the blood may be helpful for the early diagnosis and estimation of prognosis and thus have attracted much attention in recent years. Especially, neuron-specific enolase and S-100 protein have been investigated. Neuronspecific enolase was shown to be an important marker for the prognosis of global ischemia, for example, after resuscitation, but has failed to show significant correlation in focal cerebral ischemia. 19 S-100 protein is a major component of cytosol, especially in astroglial cells, and can be found in serum after experimental focal ischemic brain damage and various other brain injuries. In clinical investigation, S-100 protein did increase in the serum only after 2 or 3 days after onset of stroke when the cranial CT scan already showed clear demarcation of infarction. 20 Polyamines are present in almost all cells of the brain. 1, 3 Recent studies have shown that there is a continuous release of polyamines from cells into the extracellular space 21 to regulate cellular concentration. 22 Measurements of polyamine metabolism in brain slices after focal cerebral ischemia showed a marked increase in the ODC activity 5 and an overshoot of the putrescine concentration, which is catalyzed by ODC. However, spermidine and spermine showed a significant reduction after recirculation 23, 24 in severely damaged areas, indicating a release not only into the extracellular space but a clearing into the peripheral blood. This hypothesis is supported by the finding that polyamine release plays an important role in alteration of the blood-brain barrier in focal cerebral ischemia 25 and is important in the development of late vasogenic edema. 26 Furthermore, it has been shown that spermidine can also be released from the brain cells by depolarization stimuli, 27 as observed in the case of hypoxia, and stimulates NMDA receptor activity. 6, 28 Polyamines modulate NMDA receptors for the opening of a channel permeable for sodium, calcium, and potassium ions 29 and therefore play an important role in the ischemic cascade. The mechanisms responsible for the transport of polyamines across the cell wall in the early phase of ischemia are not fully understood. After release from brain tissue, polyamines are mainly transported in the blood by erythrocytes. 30, 31 In the presence of serum, the affinity of red blood cells for spermidine is 30-fold greater than that for other polyamines, 30 which may explain the difficulties in the measurement of spermine and putrescine. 
Els et al Polyamine Metabolism After Focal Cerebral Ischemia
The aim of our study was to investigate whether polyamine levels were elevated in human blood after focal cerebral ischemia and whether there is a correlation with the clinical outcome as well as with the volume of infarction after hemispheric stroke. Our results suggest that the measurement of spermidine is an early marker for these parameters. The results support the finding in experimental studies of focal cerebral ischemia, which showed a release of polyamines from the intracellular compartment after ischemia. 23, 32, 33 All patients in our study showed an emboligenic territorial infarction. However, many patients with an acute neurological deficit have only lacunar strokes in vulnerable areas such as the basal ganglia with severe microangiopathic alterations, before hemodynamic infarctions or an intracerebral hemorrhage. In these patients, the elevation of polyamines may not be associated with the clinical outcome or the volume of infarction.
The pathophysiological pathway of polyamines in focal cerebral ischemia is not yet fully understood. There may be an influence of the calcium buffering capacity of mitochondria by spermine 34 ; on the other hand, polyamine metabolism may sensitize NMDA receptors during the ischemic cascade. [35] [36] [37] [38] Our results indicate that the measurement of polyamines may be a useful marker for the prediction of the clinical course of focal cerebral ischemia. Therefore, polyamines reveal neuronal injury and represent an ideal marker for clinical outcome. Thus, polyamine measurement may be of help in studies of new neuroprotective agents to determine the group of patients who show a therapeutic benefit. Further studies are necessary for patients with acute focal neurological symptoms and other underlying causes, the early diagnosis of infarction, the differentiation between transitory ischemic events and manifest infarction, and the effectiveness of therapeutic interventions.
